Scientists have figured out a whole new way to cut the legs out from underneath drug-resistant bacterial infections.
The new class of antibiotic was identified by researchers at Uppsala University in Sweden, and while it has only been tested on mice, the team hopes that further development of the drug can “make an important contribution to the ongoing struggle against antibiotic resistance.”
The unique medicine, like many other antibiotics currently in development, targets the double membrane that surrounds gram-negative bacteria, like Escherichia coli, which can cause bowel and blood infections, and Klebsiella pneumoniae, which can cause lung, bladder, and blood infections.
Comments are closed.